MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B ACTIVITIES IN HEAVY SMOKERS

被引:105
作者
BERLIN, I
SAID, S
SPREUXVAROQUAUX, O
OLIVARES, R
LAUNAY, JM
PUECH, AJ
机构
[1] CTR HOSP VERSAILLES,DEPT BIOCHEM PHARMACOL & TOXICOL,VERSAILLES,FRANCE
[2] ROCHE PROD LTD,BIOSTAT UNIT,NEUILLY,FRANCE
[3] HOP ST LOUIS,FRA C BERNARD NEUROCHIM COMMUN CELLULAIRES,PARIS,FRANCE
关键词
HEAVY DEPENDENT SMOKERS; MONOAMINE OXIDASE ACTIVITY; MAO-B; DHPG; DOPAC; DOPA;
D O I
10.1016/0006-3223(95)00084-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is a strong association between depression and smoking, Because monoamine oxidase (MAO) inhibition leads to antidepressant effect and in vitro studies have shown that cigarette smoke inhibits MAO activity, it is conceivable that smoking may have an antidepressant effect, if smokers have reduced MAO activity, Therefore, we assessed platelet MAO-B activity and plasma concentration of catecholamine metabolites reflecting MAO-A activity in heavy dependent smokers and nonsmokers matched for sociodemographic characteristics. Platelet MAO-B activity plasma 3,4-dihydroxyphenylglycol, plasma 3,4-dihydroxyphenylacetic acid, and plasma 3,4-dihydroxyphenylalanine concentrations were significantly lower in smokers than in nonsmokers,,whereas plasma norepinephrine did not differ Significantly more smokers reported previous history of depression, manic episode, panic attack agoraphobia, and simple phobia. Smokers had higher scores (p < 0.001) on the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Scales. It is concluded that the activities of both forms of the MAO are reduced in heavy dependent smokers.
引用
收藏
页码:756 / 761
页数:6
相关论文
共 40 条
  • [1] DEPRESSION AND THE DYNAMICS OF SMOKING - A NATIONAL PERSPECTIVE
    ANDA, RF
    WILLIAMSON, DF
    ESCOBEDO, LG
    MAST, EE
    GIOVINO, GA
    REMINGTON, PL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (12): : 1541 - 1545
  • [2] COMPARISON OF THE MONOAMINE-OXIDASE INHIBITING PROPERTIES OF 2 REVERSIBLE AND SELECTIVE MONOAMINE OXIDASE-A INHIBITORS MOCLOBEMIDE AND TOLOXATONE, AND ASSESSMENT OF THEIR EFFECT ON PSYCHOMETRIC PERFORMANCE IN HEALTHY-SUBJECTS
    BERLIN, I
    ZIMMER, R
    THIEDE, HM
    PAYAN, C
    HERGUETA, T
    ROBIN, L
    PUECH, AJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (06) : 805 - 816
  • [3] BOULTON AA, 1988, LANCET, V1, P114
  • [4] BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P1069
  • [5] BRESLAU N, 1993, ARCH GEN PSYCHIAT, V50, P31
  • [6] BRESLAU N, 1992, AM J PSYCHIAT, V149, P464
  • [7] BROWN MJ, 1983, BR J CLIN PHARM, V15, P599
  • [8] ABNORMAL-BEHAVIOR ASSOCIATED WITH A POINT MUTATION IN THE STRUCTURAL GENE FOR MONOAMINE OXIDASE-A
    BRUNNER, HG
    NELEN, M
    BREAKEFIELD, XO
    ROPERS, HH
    VANOOST, BA
    [J]. SCIENCE, 1993, 262 (5133) : 578 - 580
  • [9] PLASMA DIHYDROXYPHENYLALANINE AND TOTAL-BODY AND REGIONAL NORADRENERGIC ACTIVITY IN HUMANS
    EISENHOFER, G
    BRUSH, JE
    CANNON, RO
    STULL, R
    KOPIN, IJ
    GOLDSTEIN, DS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) : 247 - 255
  • [10] EISENHOFER G, 1986, CLIN CHEM, V32, P2030